4DMT is Biotechnology in United States that focus on gene therapy company business. Founded in 2015. They cover business area such as product candidate, aav vector, portfolio, three therapeutic area, ophthalmology, intravitreal vector, cardiology, intravenous vector, pulmonology, aerosol, clinical trial, x-link retinitis pigmentosa, choroideremia, Fabry disease, its two IND candidate, wet age-relate macular degeneration, cystic fibrosis lung disease.
2015
( 9 years old in 2024 )
Gene Therapy Company
-
5858 Horton Street
Suite 455
Emeryville, CA 94608
United States
Private
product candidateaav vectorportfoliothree therapeutic areaophthalmologyintravitreal vectorcardiologyintravenous vectorpulmonologyaerosolclinical trialx-link retinitis pigmentosachoroideremiaFabry diseaseits two IND candidatewet age-relate macular degenerationcystic fibrosis lung disease
* We use standard office opening hours in near 4DMT's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
4DMT is Biotechnology business from United States that founded in 2015 (9 years old in 2024), 4DMT business is focusing on Gene Therapy Company.
4DMT headquarter office and corporate office address is located in 5858 Horton Street Suite 455 Emeryville, CA 94608 United States.
4DMT was founded in United States.
In 2024, 4DMT is currently focus on gene therapy company sector.
Above is snippet of Google Trends for "gene therapy company" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with 4DMT, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
